The Department of Translational Hematology & Oncology Research conducts cancer research to develop and make available novel diagnostic tools, targeted therapies and clinical trials for direct use in patient care.
More About UsThe Li Lily Wang lab studies how immune checkpoint proteins regulate anti-tumor immune responses.
Learn MoreThe Yogen Saunthararajah lab studies how to selectively target and eliminate cancer cells without harming healthy cells.
Learn MoreBy looking beyond known cancer genes, Cleveland Clinic and St. Jude Children’s Hospital researchers have found a new inherited risk factor for childhood osteosarcoma.
The researchers demonstrate how vancomycin alters staph evolution, and offer a predictive tool to guide future antibiotic decisions.
Cleveland Clinic researchers show that radiation response in endometrial cancer is impacted by p53 gene mutations, and boost effectiveness using combination therapy.
Exciting investigation and groundbreaking discovery happens every day at Cleveland Clinic. Join our team of expert researchers at the Department of Translational Hematology & Oncology Research.
View Careers